A trend of otologic diseases during the coronavirus disease 2019 pandemic period

Acta Oto-Laryngologica, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 6

Published: Feb. 3, 2025

Coronavirus disease 2019 (COVID-19) changed the practice of medicine, and various anti-contagion restrictions were implemented worldwide. This study aimed to evaluate annual trend in incidence otologic diseases during COVID-19 pandemic determine influence social on these diseases. We retrospectively reviewed number patients treated for diseases, particularly those associated with infectious pathophysiology, total otolaryngology departments at three tertiary referral centers South Korea. The who underwent ventilation tube insertion due persistent otitis media effusion (OME) significantly decreased (raw number: -37.1%, incidence: -2.04‰) after onset pandemic. However, a sharp increase was observed 2023 +42.9%, +1.63‰) when officially ended. newly diagnosed sudden sensorineural hearing loss (SSNHL) gradually increased period. Restrictive measures control spread positively influenced reduction OME. Whether is direct risk factor SSNHL remains uncertain, but potential impact virus itself or vaccine auditory system appears exist.

Language: Английский

Impact of COVID-19 vaccination on tinnitus onset and severity: a comprehensive survey study

Frontiers in Audiology and Otology, Journal Year: 2025, Volume and Issue: 3

Published: Feb. 7, 2025

Purpose The primary objective of this study was to investigate the prevalence and characteristics tinnitus related COVID-19 vaccination. Specifically, we aimed assess impact vaccination on onset severity tinnitus, including changes in loudness, pitch, anxiety, speech perception. Additionally, sought identify potential risk factors associated with new-onset exacerbation pre-existing symptoms. Design A comprehensive survey administered 372 individuals who reported or worsening following Data before after were collected. documented medical conditions, anxiety. Respondents divided into two groups: those Statistical analyses conducted compare across these groups explore associations vaccine type (mRNA vs. non-mRNA) conditions. Results Of respondents, 53% worsened symptoms vaccination, significant increases 47% respondents developed group reporting higher anxiety levels compared tinnitus. There no difference latency between mRNA vaccines (Pfizer Moderna) non-mRNA (Johnson & Johnson). Pandemic-related identified as a contributing factor Conclusions results indicate that is an increased both Significant post-vaccination, along challenges perception, emphasize need for further research auditory effects Identifying factors, such underlying health conditions psychological stress, will be crucial developing strategies management treatment vaccinated individuals.

Language: Английский

Risk of Hearing Loss in Neonates and Toddlers with in Utero Exposure to SARS‐CoV‐2

The Laryngoscope, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 4, 2024

Objective Given the prevalence of neonatal hearing loss (HL) associated with intrauterine viral exposures, goal this study is to provide information on HL in context COVID‐19 pandemic. Methods Data were drawn from Mother Baby Outcomes (COMBO) Initiative. 1007 participants completed newborn screen as part routine clinical care (COMBO‐EHR cohort) and 555 National Survey Children's Health (NSCH) at 2 and/or 3 years age for research purposes (COMBO‐RSCH cohort). Maternal SARS‐CoV‐2 infection status during pregnancy was determined through electronic health records maternal‐reported questionnaires. Results In adjusted multivariate logistic regression models covarying assessment, mode delivery, gestational there no significant association between exposure screening failure ( OR = 1.05, 95% CI 0.39–2.42, p 0.91) COMBO‐EHR cohort. COMBO‐RSCH cohort, similar non‐significant associations concern NSCH 1.19 [95% 0.30–4.24], 0.79). Conclusion There failed neonates. Similarly, based NSCH, toddlers. These results offer reassurance given widespread nature pandemic tens millions fetuses having a history exposure. Level Evidence 4 Laryngoscope , 2024

Language: Английский